Nitecapone
From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
| Skeletal formula | |
| Space-filling model | |
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C12H11NO6 |
| Molar mass | 265.221 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Nitecapone (INN; OR-462) is a drug which acts as a selective inhibitor of the enzyme catechol O-methyl transferase (COMT).[1] [2] It was patented as an antiparkinson medication but was never marketed.[1]
See also
[edit ]References
[edit ]- ^ a b F.. Macdonald (1997). Dictionary of Pharmacological Agents. CRC Press. p. 1635. ISBN 978-0-412-46630-4 . Retrieved 20 May 2012.
- ^ Nissinen E, Lindén IB, Schultz E, Kaakkola S, Männistö PT, Pohto P (August 1988). "Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the rat". European Journal of Pharmacology. 153 (2–3): 263–9. doi:10.1016/0014-2999(88)90614-0. PMID 3181288.
Stub icon
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.